These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 25612305)

  • 21. [Effect of drug therapy on frequency of adequate discharges of implanted cardioverter defibrillator].
    Tiroke A; Ganeeva ON
    Kardiologiia; 2003; 43(6):54-8. PubMed ID: 12891312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of antiarrhythmic drugs in patients with implantable cardioverter defibrillators.
    Van Herendael H; Pinter A; Ahmad K; Korley V; Mangat I; Dorian P
    Europace; 2010 May; 12(5):618-25. PubMed ID: 20304841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hybrid therapy of atrial fibrillation.
    Santini M; Pignalberi C; Ricci R; Calò L
    Ital Heart J; 2002 Oct; 3(10):571-8. PubMed ID: 12478814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Long-term outcome of pharmacological and nonpharmacological treatment for ventricular arrhythmias].
    Ohnishi S; Kasanuki H
    J Cardiol; 2000 Mar; 35 Suppl 1():75-84. PubMed ID: 10834174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical management and prevention of sudden cardiac death.
    Yousuf O; Chrispin J; Tomaselli GF; Berger RD
    Circ Res; 2015 Jun; 116(12):2020-40. PubMed ID: 26044254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and management of ventricular tachycardia.
    Naik N; Talwar KK
    J Indian Med Assoc; 2003 Feb; 101(2):62-5, 95. PubMed ID: 12841484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Dangerous arrhythmias].
    Gertsch M; Fuhrer J
    Schweiz Med Wochenschr; 1993 May; 123(17):833-43. PubMed ID: 8497770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force.
    Gorenek B; Blomström Lundqvist C; Brugada Terradellas J; Camm AJ; Hindricks G; Huber K; Kirchhof P; Kuck KH; Kudaiberdieva G; Lin T; Raviele A; Santini M; Tilz RR; Valgimigli M; Vos MA; Vrints C; Zeymer U; Lip GY; Potpara T; Fauchier L; Sticherling C; Roffi M; Widimsky P; Mehilli J; Lettino M; Schiele F; Sinnaeve P; Boriani G; Lane D; Savelieva I
    Europace; 2014 Nov; 16(11):1655-73. PubMed ID: 25172845
    [No Abstract]   [Full Text] [Related]  

  • 29. [Update Ventricular Tachycardia].
    Fürnkranz A; Makimoto H
    Dtsch Med Wochenschr; 2018 Feb; 143(3):165-168. PubMed ID: 29409086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implantable defibrillators and/or amiodarone: alternatives or complementary therapies.
    Dorian P; Newman D; Greene M
    Int J Clin Pract; 1998 Sep; 52(6):425-8. PubMed ID: 9894382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective clinical evaluation and follow-up of a cohort of consecutive VT/VF patients, using a staged-care protocol, including coronary arteriography, programmed electrical stimulation and cardiac surgery.
    Naccarella F; Rolli A; Carboni A; Finardi A; Aurier E; Favaro L; Contini S; Gherli T; Caponi D; Maranga SS; Lepera G; Bartoletti A
    G Ital Cardiol; 1999 Oct; 29(10):1142-56. PubMed ID: 10546124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Assessment of ventricular arrhythmias].
    Osswald S; Rickenbacher P; Buser PT; Pfisterer M
    Praxis (Bern 1994); 1996 Feb; 85(7):179-87. PubMed ID: 8701182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of concomitant antiarrhythmic therapy on survival in patients with implantable cardioverter defibrillators.
    Ho AT; Pai SM; Timothy P; Pai RG
    Pacing Clin Electrophysiol; 2005 Jul; 28(7):647-53. PubMed ID: 16008799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ventricular arrhythmia: role of the implantable cardioverter defibrillator and radiofrequency ablation in addition to drugs.
    Fischer A; Verma R; Gomes JA; Mehta D
    Mt Sinai J Med; 2002 Sep; 69(4):197-207. PubMed ID: 12357261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current approaches to antiarrhythmic therapy in heart failure.
    Rose-Jones LJ; Bode WD; Gehi AK
    Heart Fail Clin; 2014 Oct; 10(4):635-52. PubMed ID: 25217438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of ventricular arrhythmias after recovery from myocardial infarction.
    Mitchell LB
    Annu Rev Med; 1994; 45():119-38. PubMed ID: 7515218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute management of ventricular arrhythmias: role of antiarrhythmic agents.
    Singh BN
    Pharmacotherapy; 1997; 17(2 Pt 2):56S-64S; discussion 89S-91S. PubMed ID: 9085341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implantable cardioverter-defibrillators for treatment of sustained ventricular arrhythmias in patients with Chagas' heart disease: comparison with a control group treated with amiodarone alone.
    Gali WL; Sarabanda AV; Baggio JM; Ferreira LG; Gomes GG; Marin-Neto JA; Junqueira LF
    Europace; 2014 May; 16(5):674-80. PubMed ID: 24481778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Current concepts in diagnosis and treatment of tachyarrhythmias].
    Schwab JO; Lüderitz B
    Internist (Berl); 2005 Sep; 46(9):1021-31; quiz 1032-3. PubMed ID: 16047135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of ventricular electrical storm: a contemporary appraisal.
    Kowlgi GN; Cha YM
    Europace; 2020 Dec; 22(12):1768-1780. PubMed ID: 32984880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.